Uppsala, Sweden

Sussanne Wallenborg

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Gyros Patent Ab, Gyros Ab. Active years: 2004-2008.


% Patents Active = 66.7


Average Co-Inventor Count = 5.5

ph-index = 3

Forward Citations = 172(Granted Patents)


Company Filing History:


Years Active: 2004-2008

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Sussanne Wallenborg: Innovator in Microfluidic Technology

Introduction

Sussanne Wallenborg is a notable inventor based in Uppsala, Sweden. She has made significant contributions to the field of microfluidics, holding a total of 3 patents. Her work focuses on developing innovative devices that enhance fluidic functions and improve analytical methods.

Latest Patents

Wallenborg's latest patents include a microfluidic device that features several microchannel structures. This device is designed with an inlet port, an outlet port, and a substructure that defines fluidic functions. The arrangement of the microchannel structures is concentric around an axis of symmetry, allowing for efficient fluid transport. The invention also includes a method for presenting an analyte of a liquid sample to a mass spectrometer, transforming it into an MS-analyte for analysis.

Career Highlights

Throughout her career, Sussanne Wallenborg has worked with companies such as Gyros Patent AB and Gyros AB. Her expertise in microfluidic systems has positioned her as a key player in the development of advanced analytical technologies.

Collaborations

Wallenborg has collaborated with notable colleagues, including Per X Andersson and Helene Derand, who have contributed to her innovative projects.

Conclusion

Sussanne Wallenborg's contributions to microfluidic technology demonstrate her commitment to advancing scientific research and analytical methods. Her patents reflect her innovative spirit and dedication to improving fluidic functions in various applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…